The European Business magazine interviewed Lamberto Pedrotti, Managing Director of SIT Group.
A look at the new international dynamics of the pharmaceutical market and the strategies adopted by the SIT Group.
SIT PHARMA acquires OSTIDIL-D3 and KEFORAL
SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL
SIT Pharma acquires DERINOX® for France market
SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas
SIT Pharma acquires MIZOLLEN® for France market
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED